Projects
BISNES
project name: Bio-Inspired Self-assembled Nano-Enabled Surfaces
initiating country: The European Union
Framework Programme: FP7 programme area: Nanotech – Nanosciences, Nanotechnologies, Materials and new Production Technologies contract type: CP-FP – Collaborative Focused Research Project
contract/proposal/call number: 214538
status: active
start date: September 2008 duration: 36 months projected finish date: September 2011
Keywords
Fields of Research:
Nanobiotechnology
Nanofabrication, Growth and Self Assembly
Project Budget
total budget: € 4,594,332
Participants
Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level.
| name | organisation | state or country |
|---|---|---|
| Prof Milton Hearn | CSIRO | VIC, Australia |
| Ms Cherie Judge | University of Liverpool | United Kingdom |
Further information
summary:
Advanced nanofabrication can produce now nano-structures similar in size with single biomolecules or their self-assembled architectures. Capitalising on this strategic opportunity, BISNES focuses on the design, fabrication and implementation of biomimetic nanostructures which complement biomolecular surfaces and modulate the biomolecular activity.
The BISNES project will
(i) develop software products for the representation and quantification of bimolecular surfaces, especially those that self-assemble in long-range nano-aggregates, interacting with artificial nanostructures;
(ii) design and fabricate nanostructured surfaces and objects that complementary replicate biomolecular surfaces; and
(iii) design, fabricate and implement novel hybrid bio-devices which exhibit quantum-leap increase in capabilities (e.g., sensitivity, response time, cost) or entirely new ones.
The project will deliver demonstrated technical solutions with impact on a wide range of applications and products: ultra-sensitive bio-diagnostics and drug discovery devices; inherently bactericidal surfaces, medical devices for the in vitro study of amyloid and cytoskeleton proteins central to critical disease (e.g., neurodegenerative diseases, cancer); and hybrid nanodevices that exhibit new electromagnetic properties useful for future IT devices.
Participants
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) FRANCE
ALMA MATER STUDIORUM-UNIVERSITA DI BOLOGNA ITALY
NIL TECHNOLOGY APS - NILT NANOMASK APS DOMINICA
IMS NANOFABRICATION AG AUSTRIA
MONASH UNIVERSITY AUSTRALIA
STICHTING BIOMADE TECHNOLOGY NETHERLANDS
PHILIPS ELECTRONICS NEDERLAND B.V. NETHERLANDS
UNIVERSITATEA POLITEHNICA DIN BUCURESTI ROMANIA
Source: Cordis
